McAdam LLC’s Chemours CC Stock Holding History

McAdam LLC’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-76	Closed	-$3K	–	139
2018 Q3	$3K	Hold	76	–	–	﹤0.01%	463
2018 Q2	$3K	Hold	76	–	–	﹤0.01%	449
2018 Q1	$4K	Buy	+76	New	+$3.8K	﹤0.01%	423

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

McAdam LLC's CC Position: Q4 2018 in Review

McAdam LLC sold out of Chemours (CC) in Q4 2018, closing a stake of 76 shares — an estimated $3K sold.

McAdam LLC first reported a position in CC in Q1 2018 and held it in 3 quarters. The position peaked at $4K in Q1 2018. 506 funds tracked by Wall St. Rank hold CC as of Q4 2018.

McAdam LLC reported no remaining Chemours position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 76 Chemours shares in Q4 2018, an estimated $3K.
McAdam LLC first reported a position in Chemours in Q1 2018 and held it in 3 quarters.
McAdam LLC's Chemours position peaked at $4K in Q1 2018.
506 funds tracked by Wall St. Rank held Chemours as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.